Compositions and methods of use for a fibroblast growth factor

Details for Australian Patent Application No. 2004288217 (hide)

Owner CuraGen Corporation

Inventors Miller, Charles E.; Alsobrook, John II; Lepley, Denise M.; Eichen, Joseph; Mezes, Peter

Agent Cullen & Co

Pub. Number AU-A-2004288217

PCT Pub. Number WO2005/044991

Priority 10/702,126 04.11.03 US

Filing date 3 November 2004

Wipo publication date 19 May 2005

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/044991 Priority application(s): WO2005/044991

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004288218-Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having Class I membrane fusogenic envelope proteins

2004288202-Accessory attachment system for a ladder, and methods